Search Results - "Burrows, F.J"

Phase 1 clinical trial of marizomib (MRZ, NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 (NCT00629473) final results by Harrison, S.J, Catley, L, Price, T, Millward, M.J, Padrik, P, Underhill, C.R, Cannell, P.K, Burrows, F.J, Reich, S.D, Trikha, M, Spencer, A

Get full text

83 Effect of TG02, a kinase inhibitor targeting Erk5, on triple negative breast cancer cells by Ortíz-Ruíz, M.J, Cheatham, L.A, Meshaw, K.R, Burrows, F.J, Pandiella, A, Esparís-Ogando, A

Get full text

78 TG02, a multi-kinase inhibitor with potent single agent and chemosensitization activity against solid tumors by Burrows, F.J, Goh, K.C, Novotny-Diermayr, V, Hart, S, Tan, Y.C, Loh, Y.K, Cheatham, L.A, Meshaw, K.R, Zaknoen, S, Wood, J

Get full text

The rat placenta expresses paternal class I major histocompatibility antigens by Billington, W D, Burrows, F J

“…The expression of paternally inherited class I MHC antigens on the placental trophoblast of the rat has been investigated using a mouse anti-rat monoclonal…”
Get more information